TY - JOUR AU - Dent, R. AU - Trudeau, M. AU - Pritchard, K. I. AU - Hanna, W. M. AU - Kahn, H. K. AU - Sawka, C. A. PY - 2007 DA - 2007// TI - Triple-negative breast cancer: clinical features and patterns of recurrence JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-3045 DO - 10.1158/1078-0432.CCR-06-3045 ID - Dent2007 ER - TY - JOUR AU - Rakha, E. A. AU - El-Sayed, M. E. AU - Green, A. R. AU - Lee, A. H. AU - Robertson, J. F. AU - Ellis, I. O. PY - 2007 DA - 2007// TI - Prognostic markers in triple-negative breast cancer JO - Cancer VL - 109 UR - https://doi.org/10.1002/cncr.22381 DO - 10.1002/cncr.22381 ID - Rakha2007 ER - TY - JOUR AU - Viale, G. AU - Rotmensz, N. AU - Maisonneuve, P. AU - Bottiglieri, L. AU - Montagna, E. AU - Luini, A. PY - 2009 DA - 2009// TI - Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivity JO - Breast Cancer Res Treat VL - 116 UR - https://doi.org/10.1007/s10549-008-0206-z DO - 10.1007/s10549-008-0206-z ID - Viale2009 ER - TY - JOUR AU - Burness, M. L. AU - Grushko, T. A. AU - Olopade, O. I. PY - 2010 DA - 2010// TI - Epidermal growth factor receptor in triple-negative and basal-like breast cancer: promising clinical target or only a marker? JO - Cancer J VL - 16 UR - https://doi.org/10.1097/PPO.0b013e3181d24fc1 DO - 10.1097/PPO.0b013e3181d24fc1 ID - Burness2010 ER - TY - JOUR AU - Klijn, J. G. AU - Berns, P. M. AU - Schmitz, P. I. AU - Foekens, J. A. PY - 1992 DA - 1992// TI - The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients JO - Endocr Rev VL - 13 ID - Klijn1992 ER - TY - JOUR AU - Milanezi, F. AU - Carvalho, S. AU - Schmitt, F. C. PY - 2008 DA - 2008// TI - EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy JO - Expert Rev Mol Diagn VL - 8 UR - https://doi.org/10.1586/14737159.8.4.417 DO - 10.1586/14737159.8.4.417 ID - Milanezi2008 ER - TY - JOUR AU - Jacot, W. AU - Lopez-Crapez, E. AU - Thezenas, S. AU - Senal, R. AU - Fina, F. AU - Bibeau, F. PY - 2011 DA - 2011// TI - Lack of EGFR-activating mutations in European patients with triple-negative breast cancer could emphasise geographic and ethnic variations in breast cancer mutation profiles JO - Breast Cancer Res VL - 13 UR - https://doi.org/10.1186/bcr3079 DO - 10.1186/bcr3079 ID - Jacot2011 ER - TY - JOUR AU - Bhargava, R. AU - Gerald, W. L. AU - Li, A. R. AU - Pan, Q. AU - Lal, P. AU - Ladanyi, M. PY - 2005 DA - 2005// TI - EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations JO - Mod Pathol VL - 18 UR - https://doi.org/10.1038/modpathol.3800438 DO - 10.1038/modpathol.3800438 ID - Bhargava2005 ER - TY - JOUR AU - Toyama, T. AU - Yamashita, H. AU - Kondo, N. AU - Okuda, K. AU - Takahashi, S. AU - Sasaki, H. PY - 2008 DA - 2008// TI - Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers JO - BMC Cancer VL - 8 UR - https://doi.org/10.1186/1471-2407-8-309 DO - 10.1186/1471-2407-8-309 ID - Toyama2008 ER - TY - STD TI - Nakajima H, Ishikawa Y, Furuya M, Sano T, Ohno Y, Horiguchi J, et al. Protein expression, gene amplification, and mutational analysis of EGFR in triple-negative breast cancer. Breast Cancer. 2012. ID - ref10 ER - TY - JOUR AU - Martin, V. AU - Botta, F. AU - Zanellato, E. AU - Molinari, F. AU - Crippa, S. AU - Mazzucchelli, L. PY - 2012 DA - 2012// TI - Molecular characterization of EGFR and EGFR-downstream pathways in triple negative breast carcinomas with basal like features JO - Histol Histopathol VL - 27 UR - https://doi.org/10.1111/j.1365-2559.2011.04160.x DO - 10.1111/j.1365-2559.2011.04160.x ID - Martin2012 ER - TY - JOUR AU - Gumuskaya, B. AU - Alper, M. AU - Hucumenoglu, S. AU - Altundag, K. AU - Uner, A. AU - Guler, G. PY - 2010 DA - 2010// TI - EGFR expression and gene copy number in triple-negative breast carcinoma JO - Cancer Genet Cytogenet VL - 203 UR - https://doi.org/10.1016/j.cancergencyto.2010.07.118 DO - 10.1016/j.cancergencyto.2010.07.118 ID - Gumuskaya2010 ER - TY - JOUR AU - Miller, T. W. AU - Rexer, B. N. AU - Garrett, J. T. AU - Arteaga, C. L. PY - 2011 DA - 2011// TI - Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer JO - Breast Cancer Res VL - 13 UR - https://doi.org/10.1186/bcr3039 DO - 10.1186/bcr3039 ID - Miller2011 ER - TY - JOUR AU - Saal, L. H. AU - Holm, K. AU - Maurer, M. AU - Memeo, L. AU - Su, T. AU - Wang, X. PY - 2005 DA - 2005// TI - PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472-CAN-04-3913 DO - 10.1158/0008-5472-CAN-04-3913 ID - Saal2005 ER - TY - JOUR AU - Lopez-Knowles, E. AU - O'Toole, S. A. AU - McNeil, C. M. AU - Millar, E. K. AU - Qiu, M. R. AU - Crea, P. PY - 2010 DA - 2010// TI - PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality JO - Int J Cancer VL - 126 ID - Lopez-Knowles2010 ER - TY - JOUR AU - Kalinsky, K. AU - Jacks, L. M. AU - Heguy, A. AU - Patil, S. AU - Drobnjak, M. AU - Bhanot, U. K. PY - 2009 DA - 2009// TI - PIK3CA mutation associates with improved outcome in breast cancer JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-09-0632 DO - 10.1158/1078-0432.CCR-09-0632 ID - Kalinsky2009 ER - TY - JOUR AU - Gonzalez-Angulo, A. M. AU - Ferrer-Lozano, J. AU - Stemke-Hale, K. AU - Sahin, A. AU - Liu, S. AU - Barrera, J. A. PY - 2011 DA - 2011// TI - PI3K pathway mutations and PTEN levels in primary and metastatic breast cancer JO - Mol Cancer Ther VL - 10 UR - https://doi.org/10.1158/1535-7163.MCT-10-1089 DO - 10.1158/1535-7163.MCT-10-1089 ID - Gonzalez-Angulo2011 ER - TY - JOUR AU - Gonzalez-Angulo, A. M. AU - Stemke-Hale, K. AU - Palla, S. L. AU - Carey, M. AU - Agarwal, R. AU - Meric-Berstam, F. PY - 2009 DA - 2009// TI - Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-08-1763 DO - 10.1158/1078-0432.CCR-08-1763 ID - Gonzalez-Angulo2009 ER - TY - JOUR AU - Lamy, P. J. AU - Fina, F. AU - Bascoul-Mollevi, C. AU - Laberenne, A. C. AU - Martin, P. M. AU - Ouafik, L. PY - 2011 DA - 2011// TI - Quantification and clinical relevance of gene amplification at chromosome 17q12-q21 in human epidermal growth factor receptor 2-amplified breast cancers JO - Breast Cancer Res VL - 13 UR - https://doi.org/10.1186/bcr2824 DO - 10.1186/bcr2824 ID - Lamy2011 ER - TY - JOUR AU - Lamy, P. J. AU - Nanni, I. AU - Fina, F. AU - Bibeau, F. AU - Romain, S. AU - Dussert, C. PY - 2006 DA - 2006// TI - Reliability and discriminant validity of HER2 gene quantification and chromosome 17 aneusomy analysis by real-time PCR in primary breast cancer JO - Int J Biol Markers VL - 21 ID - Lamy2006 ER - TY - JOUR AU - Goldhirsch, A. AU - Glick, J. H. AU - Gelber, R. D. AU - Coates, A. S. AU - Thurlimann, B. AU - Senn, H. J. PY - 2005 DA - 2005// TI - Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005 JO - Ann Oncol VL - 16 UR - https://doi.org/10.1093/annonc/mdi326 DO - 10.1093/annonc/mdi326 ID - Goldhirsch2005 ER - TY - STD TI - Jacot W, Gutowski M, Azria D, Romieu G. Adjuvant early breast cancer systemic therapies according to daily used technologies. Crit Rev Oncol Hematol. 2011. ID - ref22 ER - TY - JOUR AU - Lamy, P. J. AU - Verjat, T. AU - Servanton, A. C. AU - Paye, M. AU - Leissner, P. AU - Mougin, B. PY - 2007 DA - 2007// TI - Urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 mRNA assessment in breast cancer by means of NASBA: correlation with protein expression JO - Am J Clin Pathol VL - 128 UR - https://doi.org/10.1309/K4JAF2NMD5EJU67Y DO - 10.1309/K4JAF2NMD5EJU67Y ID - Lamy2007 ER - TY - STD TI - Schmidt M, Victor A, Bratzel D, Boehm D, Cotarelo C, Lebrecht A, et al. Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer--comparison between Adjuvant! St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial. Ann Oncol. 2009;20(2):258–64. ID - ref24 ER - TY - JOUR AU - Secq, V. AU - Villeret, J. AU - Fina, F. AU - Carmassi, M. AU - Carcopino, X. AU - Garcia, S. PY - 2014 DA - 2014// TI - Triple negative breast carcinoma EGFR amplification is not associated with EGFR, Kras or ALK mutations JO - Br J Cancer VL - 110 UR - https://doi.org/10.1038/bjc.2013.794 DO - 10.1038/bjc.2013.794 ID - Secq2014 ER - TY - JOUR AU - Cho, E. Y. AU - Chang, M. H. AU - Choi, Y. L. AU - Lee, J. E. AU - Nam, S. J. AU - Yang, J. H. PY - 2011 DA - 2011// TI - Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC) JO - Cancer Chemother Pharmacol VL - 68 UR - https://doi.org/10.1007/s00280-010-1548-x DO - 10.1007/s00280-010-1548-x ID - Cho2011 ER - TY - JOUR AU - Shah, S. P. AU - Roth, A. AU - Goya, R. AU - Oloumi, A. AU - Ha, G. AU - Zhao, Y. PY - 2012 DA - 2012// TI - The clonal and mutational evolution spectrum of primary triple-negative breast cancers JO - Nature VL - 486 ID - Shah2012 ER - TY - JOUR AU - Park, H. S. AU - Jang, M. H. AU - Kim, E. J. AU - Kim, H. J. AU - Lee, H. J. AU - Kim, Y. J. PY - 2014 DA - 2014// TI - High EGFR gene copy number predicts poor outcome in triple-negative breast cancer JO - Mod Pathol VL - 27 UR - https://doi.org/10.1038/modpathol.2013.251 DO - 10.1038/modpathol.2013.251 ID - Park2014 ER - TY - JOUR AU - Samuels, Y. AU - Wang, Z. AU - Bardelli, A. AU - Silliman, N. AU - Ptak, J. AU - Szabo, S. PY - 2004 DA - 2004// TI - High frequency of mutations of the PIK3CA gene in human cancers JO - Science VL - 304 UR - https://doi.org/10.1126/science.1096502 DO - 10.1126/science.1096502 ID - Samuels2004 ER - TY - JOUR AU - Arsenic, R. AU - Lehmann, A. AU - Budczies, J. AU - Koch, I. AU - Prinzler, J. AU - Kleine-Tebbe, A. PY - 2014 DA - 2014// TI - Analysis of PIK3CA mutations in breast cancer subtypes JO - Appl Immunohistochem Mol Morphol VL - 22 UR - https://doi.org/10.1097/PDM.0b013e318297afea DO - 10.1097/PDM.0b013e318297afea ID - Arsenic2014 ER - TY - JOUR AU - Stemke-Hale, K. AU - Gonzalez-Angulo, A. M. AU - Lluch, A. AU - Neve, R. M. AU - Kuo, W. L. AU - Davies, M. PY - 2008 DA - 2008// TI - An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-6854 DO - 10.1158/0008-5472.CAN-07-6854 ID - Stemke-Hale2008 ER - TY - JOUR AU - Cizkova, M. AU - Susini, A. AU - Vacher, S. AU - Cizeron-Clairac, G. AU - Andrieu, C. AU - Driouch, K. PY - 2012 DA - 2012// TI - PIK3CA mutation impact on survival in breast cancer patients and in ERalpha, PR and ERBB2-based subgroups JO - Breast Cancer Res VL - 14 UR - https://doi.org/10.1186/bcr3113 DO - 10.1186/bcr3113 ID - Cizkova2012 ER - TY - JOUR AU - Zhao, L. AU - Vogt, P. K. PY - 2008 DA - 2008// TI - Helical domain and kinase domain mutations in p110alpha of phosphatidylinositol 3-kinase induce gain of function by different mechanisms JO - Proc Natl Acad Sci U S A VL - 105 UR - https://doi.org/10.1073/pnas.0712169105 DO - 10.1073/pnas.0712169105 ID - Zhao2008 ER - TY - STD TI - Liu YR, Jiang YZ, Zuo WJ, Yu KD, Shao ZM. PIK3CA mutations define favorable prognostic biomarkers in operable breast cancer: a systematic review and meta-analysis. OncoTargets and therapy. 2014;7:543–52. ID - ref34 ER - TY - JOUR AU - Hashimoto, K. AU - Tsuda, H. AU - Koizumi, F. AU - Shimizu, C. AU - Yonemori, K. AU - Ando, M. PY - 2014 DA - 2014// TI - Activated PI3K/AKT and MAPK pathways are potential good prognostic markers in node-positive, triple-negative breast cancer JO - Ann Oncol VL - 25 UR - https://doi.org/10.1093/annonc/mdu247 DO - 10.1093/annonc/mdu247 ID - Hashimoto2014 ER - TY - JOUR AU - Banerji, S. AU - Cibulskis, K. AU - Rangel-Escareno, C. AU - Brown, K. K. AU - Carter, S. L. AU - Frederick, A. M. PY - 2012 DA - 2012// TI - Sequence analysis of mutations and translocations across breast cancer subtypes JO - Nature VL - 486 UR - https://doi.org/10.1038/nature11154 DO - 10.1038/nature11154 ID - Banerji2012 ER - TY - JOUR AU - Inanc, M. AU - Ozkan, M. AU - Karaca, H. AU - Berk, V. AU - Bozkurt, O. AU - Duran, A. O. PY - 2014 DA - 2014// TI - Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer JO - Med Oncol VL - 31 UR - https://doi.org/10.1007/s12032-013-0801-7 DO - 10.1007/s12032-013-0801-7 ID - Inanc2014 ER - TY - JOUR AU - Iqbal, J. AU - Thike, A. A. AU - Cheok, P. Y. AU - Tse, G. M. AU - Tan, P. H. PY - 2012 DA - 2012// TI - Insulin growth factor receptor-1 expression and loss of PTEN protein predict early recurrence in triple-negative breast cancer JO - Histopathology VL - 61 ID - Iqbal2012 ER - TY - JOUR AU - Sanford, R. A. AU - Song, J. AU - Gutierrez-Barrera, A. M. AU - Profato, J. AU - Woodson, A. AU - Litton, J. K. PY - 2015 DA - 2015// TI - High incidence of germline BRCA mutation in patients with ER low-positive/PR low-positive/HER-2 neu negative tumors JO - Cancer VL - 121 UR - https://doi.org/10.1002/cncr.29572 DO - 10.1002/cncr.29572 ID - Sanford2015 ER -